J.P. Morgan, Morgan Stanley, Evercore ISI and Goldman Sachs & Co. LLC are acting as joint book-running managers for the offering. BofA Securities, Wells Fargo Securities and Citigroup are acting as ...

(RTTNews) - Ascendis Pharma A/S (ASND) said that it has priced its underwritten public offering of 2 million American Depositary Shares or "ADSs" at $150.00 per ADS. Each ADS represents one ordinary ...

Ascendis Pharma A/S (ASND) said that it has commenced an underwritten public offering of $300 million of American Depositary Shares ...

As of the date of this press release, approximately US$65.5 million of the Company's ordinary shares represented by the ADSs under the extended share repurchase program had not been utilized.

NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to deli ...

Financial analysis of JD's performance: neutral momentum, record high gross margin, mixed revenue growth, and new share ...

The ADSs have been approved for listing and are expected to begin trading on the Nasdaq on August 16, 2024, under the ticker symbol “YXT.” The offering is expected to close on August 19 ...

Polestar Automotive (PSNY) regains compliance with Nasdaq listing rules after closing bid price exceeds $1.00 for ten days.

Dubai, United Arab Emarite, September 19th, 2024, FinanceWire Largest Gathering with 20000+ Visitors and 200+ Exhibitors ...

A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American ...

The Company may continue to repurchase its ADSs through open-market transactions, privately negotiated transactions or block trades, and/or other legally permissible means, depending on market ...